Navigation Links
Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
Date:4/26/2011

SUNNYVALE, Calif., April 26, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated (NASDAQ: TOMO).

"The satisfaction of this condition represents a significant step toward the completion of the transaction and moves us one step closer to bringing together two best-in-class technologies to create the premier radiation oncology company and further improve cancer care for patients," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray.

The transaction is expected to close in June or July of 2011 and is subject to approval by TomoTherapy's shareholders and other customary closing conditions. For more information regarding this transaction, please visit: www.accuraytomotherapy.com.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 100,000 patients worldwide and currently more than 222 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Isis ... that it has earned a $4 million milestone ... ) associated with the initiation of a Phase ... multi-drug resistant (MDR), gram-negative bacterial infections.  The Phase ... to evaluate the efficacy and safety of plazomicin ...
(Date:9/17/2014)... Sept. 17, 2014 Sutro Biopharma, a biopharmaceutical ... the biopharmaceutical division of Merck KGaA, Darmstadt, ... the United States and ... license agreement to develop antibody drug conjugates (ADCs). ADCs ... drug. The antibody is thought to specifically target and ...
(Date:9/17/2014)... Pa. , Sept. 17, 2014  Fortune Oil ... officially changed its name to Manzo Pharmaceuticals, Inc. with ... to take effect today, September 17, 2014. Also taking ... The approval is a pivotal event in ... . Mr. Manzo explained, "We could not proceed with ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 2Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 3
... 3, 2011 Coast Dental Services, Inc., announced today ... the assets of Dental Technology, Inc. (DTI), doing business ... licensed  health care service plan. DTI and its subsidiaries ... Texas, employing 1,200 staff members, including 130 dentists.  The ...
... 3, 2011 The Food and Drug Administration says ... retail outlets that falsely claim to treat, prevent, or ... you’re taking a big risk unless you see a ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) View a ...
Cached Medicine Technology:Coast Dental to Acquire the Assets of SmileCare 2
(Date:9/17/2014)... Dr. Shervin Naderi, MD, FACS, one of the ... recipient of the 2014 Vitals Top 10 Doctor Award. This ... as it honors physicians that have earned the highest patient ... by his plastic surgeon colleagues as “The Nose Man,” is ... surgeons in the world. He is the founder of ...
(Date:9/17/2014)... September 17, 2014 Promising new research ... sheds more light on the potential ability of ketones ... disease dementia. The study shows that ... be caused by impaired glucose uptake and/or utilization, and ... brain function. , The study, by the Research Center ...
(Date:9/17/2014)... 2014) A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are ... appears in September 17 edition of the journal ... patients are at highest risk for reduced sperm ... eventually increase use of pre-treatment fertility preservation methods ...
(Date:9/17/2014)... leads to an explosion of flavours in your mouth. Researchers ... can mimic what happens in your mouth when you drink ... dryness in the wine. , When wine growers turn their ... processes to bring out the desired flavour in the product ... of the taste is known in wine terminology as astringency, ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... Indian news outlet, tells of a 24-year-old man named Advait ... severe back pain caused by degenerative disc disease. This ... putting pressure on his nerve roots and causing severe ... degenerative disc disease and how it can lead to ...
Breaking Medicine News(10 mins):Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3
... reactions to a,prescribed medication send more than 175,000 older ... used medications -- almost all,of them for heart disease ... March 2008 issue of the Harvard Heart Letter offers ... Warfarin: Check your bleeding time (INR) regularly. Take ...
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... is a,statement by William V. Corr, Executive Director, ... restaurants, bars and gaming,facilities, will be smoke-free beginning ... the Legislature last week and signed,into law today ... have delivered a historic victory for public health ...
... West announced today,that one of the country,s most iconic ... The Shops at The Bravern in downtown Bellevue as ... the needs of approximately 2,300,Microsoft employees who will be ... this fall., DavidBartonGym will offer Barton,s world renowned ...
... Over 200,of MemorialCare,s top leaders will participate in ... Habitat for Humanity of Orange County. The,home will be ... cerebral palsy and is confined to a wheelchair. Halls ... will be given a "makeover" with,upgrades throughout., (Photo: ...
... patient acceptance and ... ... that treats acute and chronic constipation, may be an,effective option for ... PEG 3350 products. Marketed in the,U.S. by Cumberland Pharmaceuticals, Kristalose(R) is ...
Cached Medicine News:Health News:Tips for Troublesome Medications, From the Harvard Heart Letter 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: